Compendium of Conventional and Targeted Drug Delivery Formulation Used for the Treatment and Management of the Wound Healing
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Wound healing is a complex and dynamic phenomenon that involves the restoration of normal physiology and functioning of injured tissue. The process of wound healing is primarily regulated by various cytokines, inflammatory mediators, and growth factors at the molecular level. Any intervention in the normal wound healing process leads to further tissue damage, which in turn leads to delayed wound healing. Several natural, synthetic drugs and their combinations were used to restore and accelerate the wound healing process. However, the conventional delivery carriers were not much effective, and thus, nowadays, nanocarriers are gaining much popularity since they are playing a pivotal role in drug delivery. Since nanocarriers have their own applicability and benefits (enhance the bioavailability, site-specific targeting) so, they can accelerate wound healing more efficiently. This review briefly discussed about the various events that take place during the wound healing process with emphasis on various natural, synthetic, and combination drug therapy used for accelerating wound healing and the role of nanotechnology-based approaches in chronic wound healing.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Current drug delivery - 19(2022), 2 vom: 22., Seite 192-211 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Singh, Ajay [VerfasserIn] |
---|
Links: |
---|
Themen: |
Clinical trial |
---|
Anmerkungen: |
Date Completed 01.03.2022 Date Revised 01.03.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1567201818666210727165916 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328600695 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328600695 | ||
003 | DE-627 | ||
005 | 20231225203301.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1567201818666210727165916 |2 doi | |
028 | 5 | 2 | |a pubmed24n1095.xml |
035 | |a (DE-627)NLM328600695 | ||
035 | |a (NLM)34315364 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Singh, Ajay |e verfasserin |4 aut | |
245 | 1 | 0 | |a Compendium of Conventional and Targeted Drug Delivery Formulation Used for the Treatment and Management of the Wound Healing |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2022 | ||
500 | |a Date Revised 01.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Wound healing is a complex and dynamic phenomenon that involves the restoration of normal physiology and functioning of injured tissue. The process of wound healing is primarily regulated by various cytokines, inflammatory mediators, and growth factors at the molecular level. Any intervention in the normal wound healing process leads to further tissue damage, which in turn leads to delayed wound healing. Several natural, synthetic drugs and their combinations were used to restore and accelerate the wound healing process. However, the conventional delivery carriers were not much effective, and thus, nowadays, nanocarriers are gaining much popularity since they are playing a pivotal role in drug delivery. Since nanocarriers have their own applicability and benefits (enhance the bioavailability, site-specific targeting) so, they can accelerate wound healing more efficiently. This review briefly discussed about the various events that take place during the wound healing process with emphasis on various natural, synthetic, and combination drug therapy used for accelerating wound healing and the role of nanotechnology-based approaches in chronic wound healing | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Wound healing | |
650 | 4 | |a clinical trial | |
650 | 4 | |a combination therapy | |
650 | 4 | |a kinds of wounds | |
650 | 4 | |a natural drug | |
650 | 4 | |a phytoconstituents | |
650 | 7 | |a Intercellular Signaling Peptides and Proteins |2 NLM | |
650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
700 | 1 | |a Maqsood, Zeba |e verfasserin |4 aut | |
700 | 1 | |a Iqubal, Mohammad Kashif |e verfasserin |4 aut | |
700 | 1 | |a Ali, Javed |e verfasserin |4 aut | |
700 | 1 | |a Baboota, Sanjula |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current drug delivery |d 2004 |g 19(2022), 2 vom: 22., Seite 192-211 |w (DE-627)NLM159100232 |x 1875-5704 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2022 |g number:2 |g day:22 |g pages:192-211 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1567201818666210727165916 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2022 |e 2 |b 22 |h 192-211 |